Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640 · see citing works

Fluorometric assay of proteins in the nanogram range

Böhlen, P., Stein, S., Dairman, W. M., & Udenfriend, S. (1973) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(73)80023-2 · Cited by 1,632 · see citing works

Nitric Oxide Activation of Poly(ADP-Ribose) Synthetase in Neurotoxicity

Zhang, J., Dawson, V. L., Dawson, T. M., & Snyder, S. H. (1994) · Science · doi:10.1126/science.8080500 · Cited by 1,118 · see citing works

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J., Storey, E., Srivastava, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,026 · see citing works

Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced

Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 961 · see citing works

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 956 · see citing works

Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.

Frei, B. B., Kim, M. C., & Ames, B. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4879 · Cited by 623 · see citing works

Alternative excitotoxic hypotheses

Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574 · see citing works

Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites

Frahm, J., Bruhn, H., Gyngell, M. L., Merboldt, K. D., Hänicke, W., & Sauter, R. (1989) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910110105 · Cited by 522 · see citing works

Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.

Shoffner, J. M., Lott, M. T., Voljavec, A. S., Soueidan, S. A., Costigan, D. A., & Wallace, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7952 · Cited by 505 · see citing works

Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase.

Schraufstätter, I. U., Hyslop, P. A., Hinshaw, D. B., Spragg, R. G., Sklar, L. A., & Cochrane, C. G. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4908 · Cited by 459 · see citing works

Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid

Brouillet, E., Jenkins, B. G., Hyman, B. T., Ferrante, R. J., Kowall, N. W., Srivastava, R., Roy, D. S., Rosen, B. R., & Beal, M. F. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05859.x · Cited by 367 · see citing works

Involvement of Free Radicals in Excitotoxicity In Vivo

Schulz, J. B., Henshaw, D. R., Siwek, D. F., Jenkins, B. G., Ferrante, R. J., Cipolloni, P. B., Kowall, N. W., Rosen, B. R., & Beal, M. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052239.x · Cited by 322 · see citing works

Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate

Beal, M. F., Brouillet, E., Jenkins, B. G., Henshaw, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03633.x · Cited by 297 · see citing works

Inhibition of Succinate Dehydrogenase by Malonic Acid Produces an “Excitotoxic” Lesion in Rat Striatum

Greene, J. G., Porter, R. H. P., Eller, R. V., & Greenamyre, J. T. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03634.x · Cited by 208 · see citing works

Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.

Koek, W., & Colpaert, F. C. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13353-3 · Cited by 202 · see citing works

1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism

Storey, E., Hyman, B. T., Jenkins, B. G., Brouillet, E., Miller, J. M., Rosen, B. R., & Beal, M. F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10080.x · Cited by 164 · see citing works

The enzymatic measurement of adenine nucleotides and P-creatine in picomole amounts

Lust, W. D., Feussner, G. K., Barbehenn, E. K., & Passonneau, J. V. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90144-5 · Cited by 163 · see citing works

Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone

Ihara, Y., Namba, R., Kuroda, S., SATO, T. A., & Shirabe, T. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90112-3 · Cited by 161 · see citing works

Coenzyme Q 10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease

Matthews, P. M., Ford, B., Dandurand, R. J., Eidelman, D. H., O'Connor, D., Sherwin, A. L., Karpati, G., Andermann, F., & Arnold, D. L. (1993) · Neurology · doi:10.1212/wnl.43.5.884 · Cited by 125 · see citing works

MELAS syndrome with mitochondrial tRNA Leu[UUR] mutation

Penn, A. M. W., Lee, J. W. K., Thuillier, P., Wagner, M., Maclure, K. M., Menard, M. R., Hall, L. D., & Kennaway, N. G. (1992) · Neurology · doi:10.1212/wnl.42.11.2147 · Cited by 124 · see citing works

Aminooxyacetic Acid Results in Excitotoxin Lesions by a Novel Indirect Mechanism

Beal, M. F., Swartz, K. J., Hyman, B. T., Storey, E., Finn, S. F., & Koroshetz, W. J. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08258.x · Cited by 118 · see citing works

Lateral diffusion of ubiquinone during electron transfer in phospholipid- and ubiquinone-enriched mitochondrial membranes.

Schneider, H., Lemasters, J. J., & Hackenbrock, C. R. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33893-6 · Cited by 110 · see citing works

Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q 10

Bresolin, N., Bet, L., Binda, A., Moggio, M. G., Comi, G. P., Nador, F., Ferrante, C., Carenzi, A., & Scarlato, G. (1988) · Neurology · doi:10.1212/wnl.38.6.892 · Cited by 107 · see citing works

Effect of High Doses of Dietary Vitamin E on the Concentrations of Vitamin E in Several Brain Regions, Plasma, Liver, and Adipose Tissue of Rats

Vatassery, G. T., Brin, M. F., Fahn, S., Kayden, H. J., & Traber, M. G. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01083.x · Cited by 106 · see citing works

Therapy of mitochondrial disorders

Przyrembel, H. (1987) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01812853 · Cited by 102 · see citing works

Long‐term coenzyme Q 10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency

Nishikawa, Y., Takahashi, M. M., Yorifuji, S., Nakamura, Y., Ueno, S., Tarui, S., Kozuka, T., & Nishimura, T. (1989) · Neurology · doi:10.1212/wnl.39.3.399 · Cited by 100 · see citing works

Ubiquinone Protects Cultured Neurons against Spontaneous and Excitotoxin-Induced Degeneration

Favit, A., Nicoletti, F., Scapagnini, U., & Canonico, P. L. (1992) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1992.88 · Cited by 98 · see citing works

Treatment of complex I deficiency with riboflavin

Bernsen, P. L. J. A., Gabreëls, F. J. M., Ruitenbeek, W., & Hamburger, H. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90108-b · Cited by 97 · see citing works

Malonate produces striatal lesions by indirect NMDA receptor activation

Henshaw, R., Jenkins, B. G., Schulz, J. B., Ferrante, R. J., Kowall, N. W., Rosen, B. R., & Beal, M. F. (1994) · Brain Research · doi:10.1016/0006-8993(94)91412-5 · Cited by 92 · see citing works

Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)

Abe, K., Fujimura, H., Nishikawa, Y., Yorifuji, S., Mezaki, T., Hirono, N., Nishitani, N., & Kameyama, M. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb03962.x · Cited by 76 · see citing works

A protective effect of coenzyme Q10 on ischemia and reperfusion of the isolated perfused rat heart

Ohhara, H. (1981) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(81)90229-7 · Cited by 74 · see citing works

Tissue concentrations of coenzyme Q10 in the rat following its oral and intraperitoneal administration.

Reahal, S., & Wrigglesworth, J. M. (1992) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08606-4 · Cited by 57 · see citing works

Subject Index, Vol. 39, 1989

Shew, R. L., Robinson, M. F., Olansky, L., Yee, J. A., Titishov, N., Mechoulam, R., Zimmerman, A. M., Raghoebar, M., Tiemessen, H. L. G. M., van den Berg, W. B., et al. (2008) · Pharmacology · doi:10.1159/000138630 · Cited by 18 · see citing works

Invalidity of the Rao Map Function for Three Loci

Weeks, D. E. (1994) · Human Heredity · doi:10.1159/000154213 · Cited by 12 · see citing works

Aging, energy, and oxidative stress in neurodegenerative diseases

Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434 · see citing works

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

Gilgun‐Sherki, Y., Melamed, E., & Offen, D. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00019-3 · Cited by 839 · see citing works

Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism

Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677 · see citing works

Coenzyme Q ₁₀ administration increases brain mitochondrial concentrations and exerts neuroprotective effects

Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8892 · Cited by 557 · see citing works

Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease

Beal, M. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07470.x · Cited by 523 · see citing works

Oxidative stress in Huntington’s disease

Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508 · see citing works

Energetics in the pathogenesis of neurodegenerative diseases

Beal, M. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01584-8 · Cited by 472 · see citing works

Modification of Brain Aging and Neurodegenerative Disorders by Genes, Diet, and Behavior

Mattson, M. P., Chan, S. L., & Duan, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00004.2002 · Cited by 438 · see citing works

Energy metabolism defects in Huntington's disease and effects of coenzyme Q₁₀

Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405 · see citing works

Therapeutic Effects of Coenzyme Q₁₀and Remacemide in Transgenic Mouse Models of Huntington's Disease

Ferrante, R. J., Andreassen, O. A., Dedeoglu, A., Ferrante, K. L., Jenkins, B. G., Hersch, S. M., & Beal, M. F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01592.2002 · Cited by 391 · see citing works

Mitochondria in Neurodegeneration: Acute Ischemia and Chronic Neurodegenerative Diseases

Fiskum, G. M., Murphy, A. N., & Beal, M. F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199904000-00001 · Cited by 351 · see citing works

Role of Oxidative Stress and Antioxidants in Neurodegenerative Diseases

Rao, A. V., & Balachandran, B. (2002) · Nutritional Neuroscience · doi:10.1080/1028415021000033767 · Cited by 337 · see citing works

A randomized, placebo-controlled trial of coenzyme Q ₁₀ and remacemide in Huntington’s disease

The Huntington Study Group (2001) · Neurology · doi:10.1212/wnl.57.3.397 · Cited by 312 · see citing works

Mitochondrial Approaches for Neuroprotection

Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases

Alexi, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00032-5 · Cited by 290 · see citing works

Mitochondrial Dysfunction and Oxidative Damage in Alzheimer's and Parkinson's Diseases and Coenzyme Q10 as a Potential Treatment

Beal, M. F. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041772.74810.92 · Cited by 276 · see citing works

Chronic 3-Nitropropionic Acid Treatment in Baboons Replicates the Cognitive and Motor Deficits of Huntington’s Disease

Palfi, S., Ferrante, R. J., Brouillet, E., Beal, M. F., Dolan, R., Guyot, M., Peschanski, M., & Hantraye, P. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-09-03019.1996 · Cited by 259 · see citing works

Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders

Tarnopolsky, M. A., & Beal, M. F. (2001) · Annals of Neurology · doi:10.1002/ana.1028 · Cited by 244 · see citing works

The Energetics of Huntington's Disease

Browne, S. E., & Beal, M. F. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014824.04728.dd · Cited by 240 · see citing works

Bioenergetic approaches for neuroprotection in Parkinson's disease

Beal, M. F. (2003) · Annals of Neurology · doi:10.1002/ana.10479 · Cited by 236 · see citing works

Combination therapy with Coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases

Yang, L., Calingasan, N. Y., Wille, E. J., Cormier, K., Smith, K., Ferrante, R. J., & Beal, M. F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06074.x · Cited by 232 · see citing works

Experimental therapeutics in transgenic mouse models of Huntington's disease

Beal, M. F., & Ferrante, R. J. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1386 · Cited by 224 · see citing works

The Influence of Nicotinamide on Health and Disease in the Central Nervous System

Fricker, R. A., Green, E. L., Jenkins, S. I., & Griffin, S. M. (2018) · International Journal of Tryptophan Research · doi:10.1177/1178646918776658 · Cited by 200 · see citing works

Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats

Ishrat, T., Khan, M. B., Hoda, M. N., Yousuf, S., Ahmad, M., Ansari, M. A., Ahmad, A. S., & Islam, F. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.009 · Cited by 190 · see citing works

Coenzyme Q10 effects in neurodegenerative disease

Henchcliffe, C. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5212 · Cited by 188 · see citing works

Evidence of Oxidant Damage in Huntington's Disease: Translational Strategies Using Antioxidants

Stack, E. C., Matson, W. R., & Ferrante, R. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.008 · Cited by 167 · see citing works

Coenzyme Q 10 as a Possible Treatment for Neurodegenerative Diseases

Beal, M. F. (2002) · Free Radical Research · doi:10.1080/10715760290021315 · Cited by 160 · see citing works

Antioxidants in Huntington's disease

Johri, A., & Beal, M. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.11.014 · Cited by 158 · see citing works

Therapeutic effects of coenzyme Q 10 (CoQ 10 ) and reduced CoQ 10 in the MPTP model of Parkinsonism

Cléren, C., Yang, L., Lorenzo, B. J., Calingasan, N. Y., Schomer, A. C., Sireci, A. N., Wille, E. J., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05097.x · Cited by 158 · see citing works

Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases

Schulz, J. B., Matthews, R. T., Henshaw, D. R., & Beal, M. F. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00527-7 · Cited by 155 · see citing works

Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study

Libri, V., Yandım, C., Athanasopoulos, S., Loyse, N., Natisvili, T., Law, P. P., Chan, P. K., Mohammad, T., Mauri, M., Tam, K. T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60382-2 · Cited by 152 · see citing works

Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease

Faust, K., Gehrke, S., Yang, Y., Yang, L., Beal, M. F., & Lu, B. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-109 · Cited by 151 · see citing works

Mitochondrial Disorders: Clinical and Genetic Features

Simon, D. K., & Johns, D. R. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.111 · Cited by 150 · see citing works

Three Classes of Ubiquinone Analogs Regulate the Mitochondrial Permeability Transition Pore through a Common Site

Walter, L., Nogueira, V., Leverve, X. M., Heitz, M., Bernardi, P., & Fontaine, E. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004128200 · Cited by 146 · see citing works

Progress on the Mitochondrial Permeability Transition Pore: Regulation by Complex I and Ubiquinone Analogs

Fontaine, E. M., & Bernardi, P. (1999) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1005475802350 · Cited by 146 · see citing works

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

McGarry, A. J., McDermott, M., Kieburtz, K. D., de Blieck, E. A., Beal, F. M., Marder, K. S., Ross, C. A., Shoulson, I., Gilbert, P. R., Mallonee, W. M., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003478 · Cited by 139 · see citing works

Oxidative Stress and Cognitive Decline: The Neuroprotective Role of Natural Antioxidants

Franzoni, F., Scarfò, G., Guidotti, S., Fusi, J., Асомов, М. И., & Pruneti, C. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.729757 · Cited by 136 · see citing works

Reactive Oxygen Species and p38 Mitogen-Activated Protein Kinase Activate Bax to Induce Mitochondrial Cytochrome c Release and Apoptosis in Response to Malonate

Gómez-Lázaro, M., Galindo, M. F., de Mera, R. M. M.-F., Fernández-Gómez, F.-J., Concannon, C. G., Segura, M. F., Comella, J. X., Prehn, J. H. M., & Jordán, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030718 · Cited by 136 · see citing works

Delayed Treatment With Nicotinamide (Vitamin B 3 ) Improves Neurological Outcome and Reduces Infarct Volume After Transient Focal Cerebral Ischemia in Wistar Rats

Mokudai, T., Ayoub, I. A., Sakakibara, Y., Lee, E.-J., Ogilvy, C. S., & Maynard, K. I. (2000) · Stroke · doi:10.1161/01.str.31.7.1679 · Cited by 131 · see citing works

Topical Review: Glutamate in Neurologic Diseases

Bittigau, P., & Ikonomidou, C. (1997) · Journal of Child Neurology · doi:10.1177/088307389701200802 · Cited by 131 · see citing works

Application of MRS to mouse models of neurodegenerative illness

Choi, J., Dedeoglu, A., & Jenkins, B. G. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1145 · Cited by 126 · see citing works

Mitochondria as targets for chemotherapy

Gogvadze, V. G., Orrenius, S., & Zhivotovsky, B. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0323-0 · Cited by 125 · see citing works

Coenzyme Q10 Combined With Mild Hypothermia After Cardiac Arrest

Damian, M. S., Ellenberg, D., Gildemeister, R., Lauermann, J., Simonis, G., Sauter, W., & Georgi, C. (2004) · Circulation · doi:10.1161/01.cir.0000146894.45533.c2 · Cited by 113 · see citing works

Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases

Martinelli, C., Pucci, C., Battaglini, M., Marino, A., & Ciofani, G. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201901589 · Cited by 111 · see citing works

Coenzyme Q10administration and its potential for treatment of neurodegenerative diseases

Beal, M. F. (1999) · BioFactors · doi:10.1002/biof.5520090222 · Cited by 111 · see citing works

Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats

Ayoub, I. A., Lee, E. J., Ogilvy, C. S., Beal, M. F., & Maynard, K. I. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00881-7 · Cited by 107 · see citing works

Methylmalonate toxicity in primary neuronal cultures

McLaughlin, B., NELSON, D. S., Silver, I. A., Erecińska, M., & Chesselet, M. ‐. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00594-0 · Cited by 107 · see citing works

Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington’s disease

McBride, J. L., Ramaswamy, S., Gasmi, M., Bartus, R. T., Herzog, C. D., Brandon, E. P., Zhou, L., Pitzer, M. R., Berry‐Kravis, E., & Kordower, J. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508875103 · Cited by 106 · see citing works

Quercetin, Coenzyme Q10, and l -canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain

Abdelgawad, H. M., & Khalifa, A. E. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0781 · Cited by 104 · see citing works

Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity

Schulz, J. B., Ross Henshaw, D., Matthews, R. T., & Flint Beal, M. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90033-0 · Cited by 103 · see citing works

The Role of Mitochondria in the Pathogenesis of Neurodegenerative Diseases

Manfredim, G., & Beal, M. F. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00278.x · Cited by 101 · see citing works

Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA)

Ross, C. A., Margolis, R. L., Rosenblatt, A., Ranen, N. G., Bêcher, M. W., & Aylward, E. (1997) · Medicine · doi:10.1097/00005792-199709000-00001 · Cited by 101 · see citing works

Bioenergetics in Huntington's Disease

Grünewald, T. G. P., & Beal, M. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07827.x · Cited by 100 · see citing works

N‐Acetyl‐ l ‐cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on β‐amyloid secretion and tau phosphorylation

Olivieri, G., Baysang, G., Meier, F., Müller-Spahn, F., Stähelin, H. B., Brockhaus, M., & Brack, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00090.x · Cited by 98 · see citing works

Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain

Manzar, H., Abdulhussein, D., Yap, T. E., & Cordeiro, M. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239299 · Cited by 94 · see citing works

Nutraceuticals against Neurodegeneration: A Mechanistic Insight

Dadhania, V. P., Trivedi, P. P., Vikram, A., & Tripathi, D. N. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160104142223 · Cited by 92 · see citing works

Elucidation of molecular mechanism involved in neuroprotective effect of C oenzyme Q 10 in alcohol‐induced neuropathic pain

Kandhare, A. D., Ghosh, P., Ghule, A. E., & Bodhankar, S. L. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12003 · Cited by 91 · see citing works

Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model

Yang, J., Klaidman, L. K., Chang, M. L., Kem, S., Sugawara, T., Chan, P. H., & Adams, J. D., Jr. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00939-5 · Cited by 90 · see citing works

Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition

Maciel, E. N., Kowaltowski, A. J., Schwalm, F. D., Rodrigues, J. M., Souza, D. O., Vercesi, A. E., Wajner, M., & Castilho, R. F. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02565.x · Cited by 82 · see citing works

Simultaneous Detection of Ubiquinol-10, Ubiquinone-10, and Tocopherols in Human Plasma Microsamples and Macrosamples as a Marker of Oxidative Damage in Neonates and Infants

Menke, T., Niklowitz, P., Adam, S., Weber, M. A., Schlüter, B., & Andler, W. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4579 · Cited by 79 · see citing works

S-Methylthiocitrulline, a Neuronal Nitric Oxide Synthase Inhibitor, Protects against Malonate and MPTP Neurotoxicity

Matthews, R. T., Yang, L., & Beal, M. F. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6406 · Cited by 79 · see citing works

Coenzyme Q treatment of neurodegenerative diseases of aging

Galpern, W. R., & Cudkowicz, M. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.01.004 · Cited by 78 · see citing works

Coenzyme Q10 a mitochondrial restorer for various brain disorders

Pradhan, N., Singh, C., & Singh, A. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02161-8 · Cited by 77 · see citing works

Post-treatment with nicotinamide (vitamin B3) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague–Dawley and Wistar rats

Sakakibara, Y., Mitha, A. P., Ogilvy, C. S., & Maynard, K. I. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00854-5 · Cited by 76 · see citing works

Neuroprotective effects of creatine administration against NMDA and malonate toxicity

Malcon, C., Kaddurah-Daouk, R. F., & Beal, M. F. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02038-2 · Cited by 76 · see citing works

Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3

Chan, P. K., Torres, R., Yandım, C., Law, P. P., Khadayate, S. P., Mauri, M., Groşan, C., Chapman‐Rothe, N., Giunti, P., Pook, M. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt115 · Cited by 75 · see citing works

The Adenosine A1Receptor Agonist Adenosine Amine Congener Exerts a Neuroprotective Effect against the Development of Striatal Lesions and Motor Impairments in the 3-Nitropropionic Acid Model of Neurotoxicity

Blum, D. L., Gall, D., Galas, M., d’Alcantara, P., Bantubungi, K., & Schiffmann, S. N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09122.2002 · Cited by 73 · see citing works

Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease

Tavares, R. G., dos Santos, C. E. S., Tasca, C. I., Wajner, M., Souza, D. O., & Dutra‐Filho, C. S. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00402-0 · Cited by 72 · see citing works

Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington’s disease

Lee, W., & Chang, C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.02.002 · Cited by 67 · see citing works

Nicotinamide Attenuates Focal Ischemic Brain Injury in Rats: With Special Reference to Changes in Nicotinamide and NAD+ Levels in Ischemic Core and Penumbra

Sadanaga, F., Yao, H., Tanuma, S., Nakahara, T., Hong, J. S., Ibayashi, S., Uchimura, H., & Fujishima, M. (2003) · Neurochemical Research · doi:10.1023/a:1024236614015 · Cited by 65 · see citing works

Coenzyme Q10: A novel gastroprotective effect via modulation of vascular permeability, prostaglandin E2, nitric oxide and redox status in indomethacin-induced gastric ulcer model

El-Abhar, H. S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.012 · Cited by 63 · see citing works

Huntington's Disease and Dentatorubral‐Pallidoluysian Atrophy: Proteins, Pathogenesis and Pathology

Ross, C. A., Bêcher, M. W., Colomer, V., Engelender, S., Wood, J. D., & Sham, A. H. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00898.x · Cited by 63 · see citing works

Clinical trials of coenzyme Q10 in neurological disorders

Shults, C. W., & Haas, R. (2005) · BioFactors · doi:10.1002/biof.5520250113 · Cited by 62 · see citing works

Evidence of cortical metabolic dysfunction in early Huntington's disease by single‐photon‐emission computed tomography

Sax, D. S., Powsner, R. A., Kim, A., Tilak, S., Bhatia, R. G., Cupples, L. A., & Myers, R. H. (1996) · Movement Disorders · doi:10.1002/mds.870110612 · Cited by 61 · see citing works

Protective Effect of L-Carnitine and Coenzyme Q10 on CCl4-Induced Liver Injury in Rats

Ali, S. A. (2010) · Scientia Pharmaceutica · doi:10.3797/scipharm.1006-02 · Cited by 59 · see citing works

Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease

Beal, M. F., & Shults, C. W. (2003) · BioFactors · doi:10.1002/biof.5520180218 · Cited by 58 · see citing works

Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases

Beal, M. F., & Matthews, R. T. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00024-1 · Cited by 58 · see citing works

Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10

Zhang, Y. P., Song, C. Y., Yuan, Y., Eber, A. E., Rodriguez, Y. F., Levitt, R. C., Takács, P., Yang, Z., Goldberg, R. B., & Candiotti, K. A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.05.003 · Cited by 57 · see citing works

Central Administration of Methamphetamine Synergizes with Metabolic Inhibition to Deplete Striatal Monoamines

Burrows, K. B., Nixdorf, W. L., & Yamamoto, B. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35363-7 · Cited by 57 · see citing works

MPP+Produces Progressive Neuronal Degeneration Which Is Mediated by Oxidative Stress

Fallon, J., Matthews, R. T., Hyman, B. T., & Beal, M. F. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6416 · Cited by 57 · see citing works

Parkinson's Disease: Mitochondrial Molecular Pathology, Inflammation, Statins, and Therapeutic Neuroprotective Nutrition

KONES, R. J. (2010) · Nutrition in Clinical Practice · doi:10.1177/0884533610373932 · Cited by 55 · see citing works

A high-throughput screen of real-time ATP levels in individual cells reveals mechanisms of energy failure

Mendelsohn, B. A., Bennett, N. K., Darch, M. A., Yu, K., Nguyen, M. K., Pucciarelli, D., Nelson, M. R., Horlbeck, M. A., Gilbert, L. A., Hyun, W. C., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2004624 · Cited by 55 · see citing works

Mitochondrial Toxin 3-Nitropropionic Acid Induces Cardiac and Neurotoxicity Differentially in Mice

Gabrielson, K. L., Hogue, B. A., Bohr, V. A., Cardounel, A. J., Nakajima, W., Kofler, J., Zweier, J. L., Rodríguez, E. R., Martin, L. J., de Souza-Pinto, N. C., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62536-9 · Cited by 54 · see citing works

Protective Effect of Nicotinamide on Neuronal Cells under Oxygen and Glucose Deprivation and Hypoxia/Reoxygenation

Shen, C., Huang, H., Ou, H., Chen, H., Chen, W., & Jeng, K.-C. G. (2004) · Journal of Biomedical Science · doi:10.1007/bf02256096 · Cited by 54 · see citing works

Therapeutic Effects of Coenzyme Q10 in Neurodegenerative Diseases

Beal, M. F. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82026-3 · Cited by 54 · see citing works

GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid

Fighera, M. R., Bonini, J. S., de Oliveira, T. G., Frussa‐Filho, R., da Rocha, J. B. T., Dutra‐Filho, C. S., Rubin, M. A., & Mello, C. F. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00275-3 · Cited by 53 · see citing works

PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All

Lloret, A., & Beal, M. F. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02809-1 · Cited by 52 · see citing works

Methylmalonyl-CoA Mutase Induction by Cerebral Ischemia and Neurotoxicity of the Mitochondrial Toxin Methylmalonic Acid

Narasimhan, P., Sklar, R., Murrell, M. T., Swanson, R. A., & Sharp, F. R. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-22-07336.1996 · Cited by 51 · see citing works

MPTP-induced deficits in motor activity: Neuroprotective effects of the spintrapping agent, ?-phenyl-tert-butyl-nitrone (PBN)

Fredriksson, A., Eriksson, P., & Archer, T. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291877 · Cited by 50 · see citing works

Mitochondrial encephalomyopathies: what next?

DiMauro, S. (1996) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799110 · Cited by 50 · see citing works

Attenuating effects of coenzyme Q10 and amlodipine in ulcerative colitis model in rats

Morsy, E. M. E., Kamel, R., & Ahmed, M. A. E. (2015) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1021357 · Cited by 49 · see citing works

The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?☆

Lee, J.-H., Boo, J. H., & Ryu, H. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.016 · Cited by 49 · see citing works

Intrastriatal Methylmalonic Acid Administration Induces Convulsions and TBARS Production, and Alters Na+,K+‐ATPase Activity in the Rat Striatum and Cerebral Cortex

Malfatti, C. R. M., Royes, L. F. F., Francescato, L. N., Sanabria, E., Rubin, M. A., Cavalheiro, É. A., & Mello, C. F. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.42902.x · Cited by 49 · see citing works

Mechanisms for neuronal cell death and dysfunction in Huntington's disease: pathological cross-talk between the nucleus and the mitochondria?

Sawa, A. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100223 · Cited by 49 · see citing works

Neuroprotective Effects of Thymoquinone on the Hippocampus in a Rat Model of Traumatic Brain Injury

Gülşen, İ., Ak, H., Çölçimen, N., Hakan, H., Akyol, M. E., Demır, İ., Atalay, T., Balahroğlu, R., & Rağbetli̇, M. Ç. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.09.052 · Cited by 48 · see citing works

Coenzyme Q10 Supplementation Reverses Age-Related Impairments in Spatial Learning and Lowers Protein Oxidation

Shetty, R. A., Forster, M. J., & Sumien, N. (2013) · AGE · doi:10.1007/s11357-012-9484-9 · Cited by 47 · see citing works

Q10 therapy in patients with idiopathic Parkinson's disease

Strijks, E., Kremer, H. P. H., & Horstink, M. W. I. M. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00008-3 · Cited by 45 · see citing works

Mitochondrial matters of the brain: the role in Huntington’s disease

Turner, C., & Schapira, A. H. V. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9290-y · Cited by 44 · see citing works

Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT

Darvesh, A. S., & Gudelsky, G. A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.07.009 · Cited by 44 · see citing works

Antiglutamate therapies in Huntington’s disease

Kieburtz, K. D. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6369-6_9 · Cited by 44 · see citing works

Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases

Schulz, J. B., Matthews, R. T., Henshaw, D. R., & Beal, M. F. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00527-7 · Cited by 155 · see citing works

Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10

Brouillet, E., Henshaw, D. R., Schulz, J. B., & Beal, M. F. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90044-2 · Cited by 23 · see citing works

Malonate produces striatal lesions by indirect NMDA receptor activation

Henshaw, R., Jenkins, B. G., Schulz, J. B., Ferrante, R. J., Kowall, N. W., Rosen, B. R., & Beal, M. F. (1994) · Brain Research · doi:10.1016/0006-8993(94)91412-5 · Cited by 92 · see citing works

Quinolinic Acid Impairs Redox Homeostasis, Bioenergetic, and Cell Signaling in Rat Striatum Slices: Prevention by Coenzyme Q10

Ferreira, F. S., dos Santos, T. M., Júnior, O. V. R., Silveira, J. S., Schmitz, F., & Wyse, Â. T. D. S. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00484-9 · Cited by 12 · see citing works

Coenzyme Q10administration and its potential for treatment of neurodegenerative diseases

Beal, M. F. (1999) · BioFactors · doi:10.1002/biof.5520090222 · Cited by 111 · see citing works